The leading web portal for pharmacy resources, news, education and careers

September 8, 2010

Pharmacy Choice - Pharmaceutical News - Boston Scientific Announces FDA Approval of New Leads for the Precision Plus Spinal Cord Stimulator System - September 8, 2010

Pharmacy News Article

7/29/10 - Boston Scientific Announces FDA Approval of New Leads for the Precision Plus Spinal Cord Stimulator System

Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus? Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. The Linear? 3-4 and Linear? 3-6 Percutaneous Leads offer wider contact spacing to expand the lead choices available to physicians. The Company plans to launch the products immediately in the U.S.; they were launched in Europe and other international markets earlier this year.

SCS leads are designed to deliver electrical pulses from an implantable pulse generator to the spinal cord to mask pain signals to the brain. The new leads, in combination with the recently launched W4 and D4 lead splitters, provide the broadest range of percutaneous lead configurations in the industry.